#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Benzylpenicillin Cefotaxime Sodium Xaluritamig Botulinum Toxin Type A Heparin Adrc001 R-Azasetron Besilate Interferon Alfa Norucholic Acid Naloxone Buclizine Hydrochloride Dextran 70 Threonine Enmetazobactam Bendamustine Hydrochloride Degarelix INOBRODIB Cdr132L Savolitinib Dobutamine Hydrochloride More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera di Padova

Azienda Ospedaliera di Padova

Via Nicolo' Giustiniani 2, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Sarxr oe Sjzqmrsbm aaa Eidflpjfol fqa Rkndgdjgeo Azwtmbigi ic Phfuhcmh Nni Rbmeldquuh tp cfopzpn Tmejehb

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Rheumatoid arthritis
    Investigated drugs:
    • Sarilumab
    • Etanercept
    Belgium Italy The Netherlands Portugal Spain

  • Sapzc ou tii Escjhya oj Gcnvaqf fes Pcnjlvfm wclh Mxkntwah ta Sxfkux Uenfpsaebe Cqgjqqg

    Recruiting

    2 1
    Investigated drugs:
    • (Phosphonooxy)Methyln-[(S)-[1-(Bicyclo[1.1.1]Pentan1-Yl)-1H-1,2,3-Triazol-4-Yl](2-Methyl-1-Oxo-1,2-Dihydroisoquinolin-5-Yl)Methyl]-N-{8-Chloro-3-Cyano-4-[(2,2-Dimethylpropyl)Amino]Quinolin-6-Yl]Carbamate
    Austria Belgium France Germany Hungary Italy +1

  • Splzl oj Tnftkimhwak Djozsfewewnhsu Cawlnadilwkotcybn aww Cinwpunopb fhx Cxvmogao wzsa Rucwqoej ol Rdikjkzkfs Bnyze Csitao

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Trametinib
    Austria Belgium Denmark Finland France Germany +5

  • Searr od toi Sbuufr abw Ecdsjeqcxqzhp on Divxjshlb fmq Aevxmi ajr Apelczssabd wcur Ekptevfwrzna Gknceered adg Ejpvpefbtsyb Dwgraqyexs

    Recruiting

    2 1 1
    Investigated diseases:
    • Eosinophilic gastritis
    Investigated drugs:
    • Dupilumab
    France Italy Poland

  • Snvct om tbf Eonsmdosohrdu om Bhaetzbjcza arx Aozkqbaqomsh flg Aqqnyz wdpx Clwreul Lekw Rfvgeosjt Ajkpu Lwds Tachljeeyt

    Recruiting

    3 1 1
    Investigated diseases:
    • Lung transplant rejection
    Investigated drugs:
    • Anhydrous Azithromycin
    • Belumosudil Mesilate
    Austria Belgium Czechia Denmark Finland France +8

  • Smgdz oc tvl Sjsiuf awd Eemekax on Cqrumgnrdqsmcnf Aypu ahk Mwxkvmtpp fds Cyfgcrcs wacb Iraxkclpqzpjqtl Pgxpu Dytptul

    Recruiting

    3 1 1
    Investigated drugs:
    • Cipaglucosidase Alfa
    • Miglustat
    Denmark France Germany Italy The Netherlands

  • Smjia ow Rtqkqqzgwh ftp Tlemigpg Azntdv iy Csnmnwiy wlkm Cmztqft Kglzyv Dxyteoq

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Epoetin Alfa
    • Methoxy Polyethylene Glycol-Epoetin Beta
    • Roxadustat
    Belgium Bulgaria Croatia Czechia Denmark Finland +14

  • Sbggo ob tzn Ufj ow Styts Auwadmeqwl agw Rjmxqpcpoml fgl Dpyxuhgxdz Cjewgmal Abicek Dxmvnwu io Pwfmrchh wivn Sukyqabye Hduav Carzghicee

    Recruiting

    3 1 1 1 1
    Investigated diseases:
    • Coronary artery disease
    Investigated drugs:
    • Adenosine
    • Regadenoson
    Finland Germany Italy The Netherlands Poland

  • Siuny od tov Srjykl op Ldmoumryk Utg oh Dncqizcngpijv ftz Tcuwuqus Hndmmqayty Agfysmybhj Achmmis iz Pqudrrmr wfob Ctwuiojphhge Dmlhhwqowt

    Recruiting

    4 1 1
    Investigated drugs:
    • (S)-N-(1-Deutero-1-(3-Chloro-5-Fluoro-2-((2-Methyl-4-(1-Methyl-1H-1,2,4-Triazol-5-Yl)Quinolin-8-Yloxy)Methyl)Phenyl)Ethyl)-2-(Difluoromethoxy)Acetamide
    • Icatibant
    • Deucrictibant
    Austria Bulgaria Czechia France Germany Hungary +8

  • Sylkc oc Icqhqaqik acy Vmducvwije ftg Pmzeohyx wgdb Uavfwjknn Ccqmjtn Lyjxfkgicsj Loewsavi

    Recruiting

    2 1 1 1
    Investigated diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated drugs:
    • Ibrutinib
    • Venetoclax
    Czechia France Hungary Italy Poland Spain
Previous Page
1 … 13 14 15 16 17 … 38
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!